Artikel
Infiltration of the subventricular zone in low-grade gliomas – molecular markers, management and outcome
Infiltration der subventrikulären Zone durch niedriggradige Gliome – molekulare Marker, Behandlung und Therapieergebnisse
Suche in Medline nach
Autoren
Veröffentlicht: | 26. Juni 2020 |
---|
Gliederung
Text
Objective: The subventricular zone (SVZ) represents the largest adult neural stem cell niche. Primary involvement of the SVZ is associated with decreased survival in high-grade glioma, however, clinical experience with low-grade glioma (LGG) is limited.
Methods: We retrospectively reviewed our institutional database of the Division of Neuro-Oncology for patients with LGG, WHO grade II°. We recorded imaging findings; histopathological as well as molecular information; therapeutic approaches; and outcome.
Results: 182 patients treated for LGG were identified, including 97 oligodendrogliomas and 85 astrocytomas. 78 of the 182 patients (43%) were found to have SVZ-involving LGG. Age, sex ratio, histopathology, MGMT promotor methylation status, and IDH mutation status did not differ between SVZ-involving LGG and non-SVZ-involving LGG. Symptoms were non-specific in both groups, and attributed to tumor mass effect. First-line therapeutic approaches included surgery, radiotherapy, chemotherapy, and wait-and-scan approaches, and did not differ between both groups. Mean follow-up time was 59 months.Overall, 43 patients (24%) showed malignant progression to high-grade glioma during follow-up. Involvement of the SVZ predicted shorter time to malignant progression (p= 0.002). Only in LGG involving the SVZ, there was a trend that therapy other than wait-and-scan might be associated with longer time to malignant progression (p= 0.078).Median overall survival was not reached after ten years. Twelve patients with SVZ-involving LGG had died at database closure, whereas only six patients with non-SVZ-involving LGG died (7% vs. 3%). SVZ involvement correlated negatively with overall survival (p= 0.023). MGMT promotor methylation (p= 0.001) and IDH mutation (p= 0.001) were positive prognostic markers for survival among LGG involving the subventricular zone.
Conclusion: SVZ involvement may convey a risk factor for malignant progression and outcome in LGG patients. Aggressive first-line therapy might be recommended in LGG involving the SVZ.MGMT promotor methylation status and IDH mutation status mayt be useful tools to further guide therapeutic approaches in such tumors.